Compare Badger Meter Inc (BMI) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? Badger Meter Inc trades at $137.51 (market cap $3.93B), while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 34.2× Badger Meter Inc's market cap, and Badger Meter Inc pays a 1.18% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| BMI | VRTX | |
|---|---|---|
Market Cap | $3.93B | $134.25B |
Sector | Technology | Health |
52-Week High | $193.09 | $529.65 |
52-Week Low | $113.41 | $376.62 |
Enterprise Value | $3.84B | $128.37B |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →
